Venus Medtech (Hangzhou) Inc. (2500)の価格はいくらですか

Venus Medtech (Hangzhou) Inc. (2500)の価格は$0.13048475です

Venus Medtech (Hangzhou) Inc. (2500)の時価総額は何ですか

Venus Medtech (Hangzhou) Inc. (2500)の時価総額は$57.55Mです

Venus Medtech (Hangzhou) Inc.（2500）株式分割

Venus Medtech (Hangzhou) Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of bioprosthetic heart valves in Mainland China and internationally. The company’s offers transcatheter aortic heart valve replacement products, such as VenusA-Valve, VenusA-Plus, VenusA-Pro, and VenusA-Deluxe; and VenusP-Valve, a transcatheter pulmonary valve system to treat the patients suffering with moderate to severe pulmonary regurgitation with or without right ventricular outflow tract stenosis. It also develops Venus-Vitae, a balloon-expandable dry-tissue product; Venus-PowerX, a self-expanding dry-tissue product; Cardiovalve, a transcatheter valve replacement system for the treatment of patients with mitral regurgitation and in pivotal clinical trial for the treatment of patients with tricuspid regurgitation; Liwen RF, a radiofrequency ablation system for the treatment of hypertrophic cardiomyopathy; and renal artery denervation ablation system for the treatment of hypertension. In addition, the company offers procedural accessories comprising catheter sheath product and balloon catheter. Venus Medtech (Hangzhou) Inc. was incorporated in 2009 and is headquartered in Hangzhou, the People’s Republic of China.

年	株式分割	分割比率	累積分割比率
提供された日付のデータは十分ではありません。

年

株式分割

分割比率

累積分割比率

提供された日付のデータは十分ではありません。

企業	株式分割の回数	累積分割比率	国
STERIS plc STE.US	2	x4	IE
Shanghai United Imaging Healthcare Co., Ltd. 688271.SS	0	-	CN
Ypsomed Holding AG YPSN.SW	0	-	CH
Medacta Group S.A. MOVE.SW	0	-	CH
Jafron Biomedical Co.,Ltd. 300529.SZ	0	-	CN

企業

株式分割の回数

累積分割比率

国